ARL5C

 

Full name: ADP ribosylation factor like GTPase 5C Alias Symbol: 
Type: protein-coding gene Cytoband: 17q12
Entrez ID: 390790 HGNC ID: HGNC:31111 Ensembl Gene: ENSG00000141748 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of ARL5C:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 ARL5C 390790 1560136_at -0.0601 0.8453
GSE26886 ARL5C 390790 1560136_at -0.3258 0.0090
GSE45670 ARL5C 390790 1560136_at -0.1602 0.1639
GSE53622 ARL5C 390790 90671 0.2226 0.0028
GSE53624 ARL5C 390790 90671 0.0425 0.6268
GSE63941 ARL5C 390790 1560136_at 0.1037 0.5433
GSE77861 ARL5C 390790 1560136_at -0.2560 0.0125
GSE97050 ARL5C 390790 A_33_P3284596 0.0962 0.6480
TCGA ARL5C 390790 RNAseq 1.2275 0.3324

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by ARL5C expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of ARL5C:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 ARL5C 390790 7 1 22
GSE20123 ARL5C 390790 7 1 22
GSE43470 ARL5C 390790 1 1 41
GSE46452 ARL5C 390790 34 0 25
GSE47630 ARL5C 390790 8 1 31
GSE54993 ARL5C 390790 3 4 63
GSE54994 ARL5C 390790 8 5 40
GSE60625 ARL5C 390790 4 0 7
GSE74703 ARL5C 390790 1 0 35
GSE74704 ARL5C 390790 4 1 15
TCGA ARL5C 390790 20 8 68

Total number of gains: 97; Total number of losses: 22; Total Number of normals: 369.  


 

Somatic mutations of ARL5C:

 

Generating mutation plots.

 

Highly correlated genes for ARL5C:

 

Showing top 20/260 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
ARL5CATP2B20.734471303
ARL5CMAG0.713701303
ARL5CSLC6A30.702274303
ARL5CACBD40.697602303
ARL5CSIM10.69341303
ARL5CPTK60.692506404
ARL5CRNF1570.691836403
ARL5CZAN0.689988303
ARL5CADAMTSL40.688339403
ARL5CGHRHR0.685508303
ARL5CTNNI3K0.685379303
ARL5CSTRC0.684851303
ARL5CNPPB0.68378303
ARL5CODF3L20.682423303
ARL5CALS2CL0.68163303
ARL5CPRB40.681618303
ARL5CMPO0.676677303
ARL5CSLC6A190.673352303
ARL5CCLDN90.673264404
ARL5CEPHA20.670736303

For details and further investigation, click here